Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in non-diabetic heart failure patients
NCT05177588Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jul 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in heart failure with reduced ejection fraction (HFrEF), sponsored by Cairo University. Started Jul 2021; status: completed.
02
Drugs
metformin
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT05177588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05177588.